Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage

go back to reference Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545PubMedCrossRef Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545PubMedCrossRef

go back to reference Il’yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, Kritchevsky SB (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14:2413–2418PubMedCrossRef Il’yasova D, Colbert LH, Harris TB, Newman AB, Bauer DC, Satterfield S, Kritchevsky SB (2005) Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev 14:2413–2418PubMedCrossRef

go back to reference Grote VA, Kaaks R, Nieters A, Tjonneland A, Halkjaer J, Overvad K, Skjelbo Nielsen MR, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Teucher B, Becker S, Pischon T, Boeing H, Trichopoulou A, Cassapa C, Stratigakou V, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Rodriguez L, Duell EJ, Sanchez MJ, Dorronsoro M, Navarro C, Gurrea AB, Siersema PD, Peeters PH, Ye W, Sund M, Lindkvist B, Johansen D, Khaw KT, Wareham N, Allen NE, Travis RC, Fedirko V, Jenab M, Michaud DS, Chuang SC, Romaguera D, Bueno-de-Mesquita HB, Rohrmann S (2012) Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer 106(11):1866–1874. doi:10.1038/bjc.2012.172 PubMedCentralPubMedCrossRef Grote VA, Kaaks R, Nieters A, Tjonneland A, Halkjaer J, Overvad K, Skjelbo Nielsen MR, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Teucher B, Becker S, Pischon T, Boeing H, Trichopoulou A, Cassapa C, Stratigakou V, Palli D, Krogh V, Tumino R, Vineis P, Panico S, Rodriguez L, Duell EJ, Sanchez MJ, Dorronsoro M, Navarro C, Gurrea AB, Siersema PD, Peeters PH, Ye W, Sund M, Lindkvist B, Johansen D, Khaw KT, Wareham N, Allen NE, Travis RC, Fedirko V, Jenab M, Michaud DS, Chuang SC, Romaguera D, Bueno-de-Mesquita HB, Rohrmann S (2012) Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Br J Cancer 106(11):1866–1874. doi:10.​1038/​bjc.​2012.​172 PubMedCentralPubMedCrossRef

go back to reference Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397PubMedCrossRef Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350:1387–1397PubMedCrossRef

go back to reference Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Bjorkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D’Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engstrom G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jorgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. The New England journal of medicine 367(14):1310–1320. doi:10.1056/NEJMoa1107477 PubMedCrossRef Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Bjorkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D’Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engstrom G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jorgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. The New England journal of medicine 367(14):1310–1320. doi:10.​1056/​NEJMoa1107477 PubMedCrossRef

go back to reference Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327–334PubMedCrossRef Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327–334PubMedCrossRef

go back to reference Al-Delaimy WK, Jansen EH, Peeters PH, van der Laan JD, van Noord PA, Boshuizen HC, van der Schouw YT, Jenab M, Ferrari P, Bueno-de-Mesquita HB (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11:370–382PubMedCrossRef Al-Delaimy WK, Jansen EH, Peeters PH, van der Laan JD, van Noord PA, Boshuizen HC, van der Schouw YT, Jenab M, Ferrari P, Bueno-de-Mesquita HB (2006) Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11:370–382PubMedCrossRef

go back to reference Block G, Dietrich M, Norkus E, Jensen C, Benowitz NL, Morrow JD, Hudes M, Packer L (2006) Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology 17:404–412PubMedCrossRef Block G, Dietrich M, Norkus E, Jensen C, Benowitz NL, Morrow JD, Hudes M, Packer L (2006) Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology 17:404–412PubMedCrossRef

go back to reference Cava F, Gonzalez C, Pascual MJ, Navajo JA, Gonzalez-Buitrago JM (2000) Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals. Cytokine 12(9):1423–1425. doi:10.1006/cyto.2000.0714 PubMedCrossRef Cava F, Gonzalez C, Pascual MJ, Navajo JA, Gonzalez-Buitrago JM (2000) Biological variation of interleukin 6 (IL-6) and soluble interleukin 2 receptor (sIL2R) in serum of healthy individuals. Cytokine 12(9):1423–1425. doi:10.​1006/​cyto.​2000.​0714 PubMedCrossRef

go back to reference Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E (2010) Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes 3:302. doi:10.1186/1756-0500-3-302 PubMedCentralPubMedCrossRef Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, Marrangoni AM, Nolen BM, Ohlson N, Zeleniuch-Jacquotte A, Lundin E (2010) Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes 3:302. doi:10.​1186/​1756-0500-3-302 PubMedCentralPubMedCrossRef

go back to reference DeGoma EM, French B, Dunbar RL, Allison MA, Mohler ER 3rd, Budoff MJ (2012) Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 224(1):274–279. doi:10.1016/j.atherosclerosis.2012.07.017 PubMedCrossRef DeGoma EM, French B, Dunbar RL, Allison MA, Mohler ER 3rd, Budoff MJ (2012) Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 224(1):274–279. doi:10.​1016/​j.​atherosclerosis.​2012.​07.​017 PubMedCrossRef

go back to reference Epstein MM, Breen EC, Magpantay L, Detels R, Lepone L, Penugonda S, Bream JH, Jacobson LP, Martinez-Maza O, Birmann BM (2013) Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men. Cancer Epidemiol Biomarkers Prev 22(11):2009–2015. doi:10.1158/1055-9965.EPI-13-0379 PubMedCrossRef Epstein MM, Breen EC, Magpantay L, Detels R, Lepone L, Penugonda S, Bream JH, Jacobson LP, Martinez-Maza O, Birmann BM (2013) Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men. Cancer Epidemiol Biomarkers Prev 22(11):2009–2015. doi:10.​1158/​1055-9965.​EPI-13-0379 PubMedCrossRef

go back to reference Gonzalez C, Cava F, Ayllon A, Guevara P, Navajo JA, Gonzalez-Buitrago JM (2001) Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals. Clinical Chem Lab Med 39(9):836–841. doi:10.1515/CCLM.2001.139 CrossRef Gonzalez C, Cava F, Ayllon A, Guevara P, Navajo JA, Gonzalez-Buitrago JM (2001) Biological variation of interleukin-1beta, interleukin-8 and tumor necrosis factor-alpha in serum of healthy individuals. Clinical Chem Lab Med 39(9):836–841. doi:10.​1515/​CCLM.​2001.​139 CrossRef

go back to reference Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Marrangoni A, Toniolo P, Lokshin AE, Arslan AA (2009) Reproducibility of serum cytokines and growth factors. Cytokine 45:44–49PubMedCentralPubMedCrossRef Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, Shore RE, Marrangoni A, Toniolo P, Lokshin AE, Arslan AA (2009) Reproducibility of serum cytokines and growth factors. Cytokine 45:44–49PubMedCentralPubMedCrossRef

go back to reference Ho GY, Xue XN, Burk RD, Kaplan RC, Cornell E, Cushman M (2005) Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women. Cytokine 30:1–6PubMedCrossRef Ho GY, Xue XN, Burk RD, Kaplan RC, Cornell E, Cushman M (2005) Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women. Cytokine 30:1–6PubMedCrossRef

go back to reference Hofmann JN, Yu K, Bagni RK, Lan Q, Rothman N, Purdue MP (2011) Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cytokine 56(2):145–148. doi:10.1016/j.cyto.2011.06.012 PubMedCentralPubMedCrossRef Hofmann JN, Yu K, Bagni RK, Lan Q, Rothman N, Purdue MP (2011) Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. Cytokine 56(2):145–148. doi:10.​1016/​j.​cyto.​2011.​06.​012 PubMedCentralPubMedCrossRef

go back to reference Kayaba K, Ishikawa S, Gotoh T, Nago N, Kajii E, Nakamura Y, Kario K (2000) Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: the Jichi Medical School Cohort Study at Yamato, 1993–1998. Jpn Circ J 64(4):303–308PubMedCrossRef Kayaba K, Ishikawa S, Gotoh T, Nago N, Kajii E, Nakamura Y, Kario K (2000) Five-year intra-individual variability in C-reactive protein levels in a Japanese population-based study: the Jichi Medical School Cohort Study at Yamato, 1993–1998. Jpn Circ J 64(4):303–308PubMedCrossRef

go back to reference Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D, Fazio S, Linton MF, Zheng W, Shu XO (2007) Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 16:2464–2470PubMedCrossRef Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D, Fazio S, Linton MF, Zheng W, Shu XO (2007) Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 16:2464–2470PubMedCrossRef

go back to reference Nasermoaddeli A, Sekine M, Kagamimori S (2006) Intra-individual variability of high-sensitivity C-reactive protein: age-related variations over time in Japanese subjects. Circ J 70:559–563PubMedCrossRef Nasermoaddeli A, Sekine M, Kagamimori S (2006) Intra-individual variability of high-sensitivity C-reactive protein: age-related variations over time in Japanese subjects. Circ J 70:559–563PubMedCrossRef

go back to reference Navarro SL, Brasky TM, Schwarz Y, Song X, Wang CY, Kristal AR, Kratz M, White E, Lampe JW (2012) Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals. Cancer Epidemiol Biomarkers Prev 21(7):1167–1170. doi:10.1158/1055-9965.EPI-12-0110 PubMedCentralPubMedCrossRef Navarro SL, Brasky TM, Schwarz Y, Song X, Wang CY, Kristal AR, Kratz M, White E, Lampe JW (2012) Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals. Cancer Epidemiol Biomarkers Prev 21(7):1167–1170. doi:10.​1158/​1055-9965.​EPI-12-0110 PubMedCentralPubMedCrossRef

go back to reference Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E (2001) Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444–450PubMed Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E (2001) Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 47:444–450PubMed

go back to reference Rao KM, Pieper CS, Currie MS, Cohen HJ (1994) Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 102:802–805PubMed Rao KM, Pieper CS, Currie MS, Cohen HJ (1994) Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 102:802–805PubMed

go back to reference Hardikar S, Onstad L, Blount PL, Odze RD, Reid BJ, Vaughan TL (2013) The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett’s esophagus. PLoS ONE 8(1):e52192. doi:10.1371/journal.pone.0052192 PubMedCentralPubMedCrossRef Hardikar S, Onstad L, Blount PL, Odze RD, Reid BJ, Vaughan TL (2013) The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett’s esophagus. PLoS ONE 8(1):e52192. doi:10.​1371/​journal.​pone.​0052192 PubMedCentralPubMedCrossRef

go back to reference Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ (2002) Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 11(8):745–752PubMed Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ (2002) Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev 11(8):745–752PubMed

go back to reference Ertan A, Younes M (2000) Barrett’s esophagus. Dig Dis Sci 45:1670–1673PubMedCrossRef Ertan A, Younes M (2000) Barrett’s esophagus. Dig Dis Sci 45:1670–1673PubMedCrossRef

go back to reference Oh DS, Demeester SR (2010) Pathophysiology and treatment of Barrett’s esophagus. World J Gastroenterol 16:3762–3772PubMedCentralPubMedCrossRef Oh DS, Demeester SR (2010) Pathophysiology and treatment of Barrett’s esophagus. World J Gastroenterol 16:3762–3772PubMedCentralPubMedCrossRef

go back to reference Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428PubMedCrossRef Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86(2):420–428PubMedCrossRef

go back to reference Rosner B (2000) Fundamentals of biostatistics, vol 5th. Vol book, whole. Duxbury, Pacific Grove Rosner B (2000) Fundamentals of biostatistics, vol 5th. Vol book, whole. Duxbury, Pacific Grove

go back to reference Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR (1992) Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 153(1–2):115–124PubMedCrossRef Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR (1992) Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods 153(1–2):115–124PubMedCrossRef

go back to reference Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978PubMedCrossRef Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW (1999) C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978PubMedCrossRef

go back to reference White E (2011) Measurement error in biomarkers: sources, assessment, and impact on studies. IARC Sci Publ 163:143–161PubMed White E (2011) Measurement error in biomarkers: sources, assessment, and impact on studies. IARC Sci Publ 163:143–161PubMed

go back to reference White E, Armstrong BK, Saracci R (2008) Principles of exposure measurement in epidemiology, 2nd edn, vol book, whole. Oxford University Press, USA White E, Armstrong BK, Saracci R (2008) Principles of exposure measurement in epidemiology, 2nd edn, vol book, whole. Oxford University Press, USA

go back to reference de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V (2009) Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 10:52PubMedCentralPubMedCrossRef de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V (2009) Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays. BMC Immunol 10:52PubMedCentralPubMedCrossRef

go back to reference Tworoger SS, Hankinson SE (2006) Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 17(7):889–899. doi:10.1007/s10552-006-0035-5 PubMedCrossRef Tworoger SS, Hankinson SE (2006) Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 17(7):889–899. doi:10.​1007/​s10552-006-0035-5 PubMedCrossRef

go back to reference House RV (2001) Cytokine measurement techniques for assessing hypersensitivity. Toxicology 158(1–2):51–58PubMedCrossRef House RV (2001) Cytokine measurement techniques for assessing hypersensitivity. Toxicology 158(1–2):51–58PubMedCrossRef